Cargando…
Effect of Amifostine in Head and Neck Cancer Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials
BACKGROUND: Amifostine is the most clinical used chemical radioprotector, but its effect in patients treated with radiation is not consistent. METHODS: By searching Medline, CENTRAL, EMBASE, ASCO, ESMO, and CNKI databases, the published randomized controlled trials (RCTs) about the efficacy of amifo...
Autores principales: | Gu, Jundong, Zhu, Siwei, Li, Xuebing, Wu, Hua, Li, Yang, Hua, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008569/ https://www.ncbi.nlm.nih.gov/pubmed/24788761 http://dx.doi.org/10.1371/journal.pone.0095968 |
Ejemplares similares
-
A Meta-Analysis of the Relationship Between RARβ Gene Promoter Methylation and Non-Small Cell Lung Cancer
por: Hua, Feng, et al.
Publicado: (2014) -
Could Amifostine Prevent Experimental Radiotherapy-Induced Acute Pericarditis?
por: Bahat, Zümrüt, et al.
Publicado: (2022) -
Amifostine Before Radiotherapy: A Rare Cause of SJS-TEN Overlap
por: Sengupta, Sujata
Publicado: (2015) -
Metabolomic studies in tissues of mice treated with amifostine and exposed to gamma-radiation
por: Cheema, Amrita K., et al.
Publicado: (2019) -
Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis
por: Katsanos, Konstantinos H, et al.
Publicado: (2010)